메뉴 건너뛰기




Volumn 5, Issue 1, 2010, Pages 130-139

Novel imatinib derivatives with altered specificity between Bcr-Abl and FMS, KIT, and PDGF receptors

Author keywords

Drug design; Imatinib; Kinase inhibitors; Oncogenes; Synthesis

Indexed keywords

IMATINIB; N [2 METHYL 3 (4 PYRIDIN 2 YLPYRIMIDIN 2 YLAMINO)PHENYL] 3,5 DINITROBENZAMIDE; N [2 METHYL 3 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 3,5 DINITROBENZAMIDE; N [2 METHYL 3 (4 PYRIDIN 4 YLPYRIMIDIN 2 YLAMINO)PHENYL] 3,5 DINITROBENZAMIDE; N [2 METHYL 4 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 3,5 DINITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 2 YLPYRIMIDIN 2 YLAMINO)PHENYL] 3,5 DINITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 2 CHLORO 3 NITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 2 CHLORO 4 NITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 2 CHLORO 5 NITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 2 FLUORO 5 NITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 2 METHYL 3 NITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 2 METHYL 5 NITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 3 NITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 3,5 DINITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 4 CHLORO 3 NITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 4 FLUORO 3 NITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 4 METHYL 3 NITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 4 NITRO 2 TRIFLUOROMETHYLBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 4 NITRO 3 TRIFLUOROMETHYLBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 4 NITROBENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL]BENZAMIDE; N [2 METHYL 5 (4 PYRIDIN 4 YLPYRIMIDIN 2 YLAMINO)PHENYL] 3,5 DINITROBENZAMIDE; N [4 METHYL 3 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 2 CHLORO 3 NITROBENZAMIDE; N [4 METHYL 3 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 2 CHLORO 4 NITROBENZAMIDE; N [4 METHYL 3 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 2 FLOURO 5 NITROBENZAMIDE; N [4 METHYL 3 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 3,5 DINITROBENZAMIDE; N [4 METHYL 3 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 4 CHLORO 3 NITROBENZAMIDE; N [4 METHYL 3 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 4 FLOURO 3 NITROBENZAMIDE; N [4 METHYL 3 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 4 NITRO 2 TRIFLUOROMETHYLBENZAMIDE; N [4 METHYL 3 (4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)PHENYL] 4 NITRO 3 TRIFLUOROMETHYLBENZAMIDE; UNCLASSIFIED DRUG;

EID: 74849135229     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200900394     Document Type: Article
Times cited : (17)

References (34)
  • 11
    • 0035413617 scopus 로고    scopus 로고
    • a) A. J. Bridges, Chem. Rev. 2001, 101, 2541-2571;
    • (2001) Chem. Rev , vol.101 , pp. 2541-2571
    • Bridges, A.J.1
  • 13
    • 0038245253 scopus 로고    scopus 로고
    • Angew. Chem. Int. Ed. 2003, 42, 2122-2138.
    • (2003) Angew. Chem. Int. Ed , vol.42 , pp. 2122-2138


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.